Coagulation/Hemostasis Analyzer Market by Product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institutes, Hospitals) - Forecast to 2019

血液凝固分析装置の世界市場

◆タイトル:Coagulation/Hemostasis Analyzer Market by Product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institutes, Hospitals) - Forecast to 2019
◆商品コード:MAM-MD-3255
◆調査・発行会社:MarketsandMarkets
◆発行日:2015年3月20日
◆ページ数:213
◆レポート形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD5,650 ⇒換算¥610,200見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥718,200見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥880,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、血液凝固分析装置の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観、市場シェア分析、市場環境分析、製品別分析、検査種類別分析、需要先別分析、地域別分析、市場規模及び予測、競争状況、関連企業分析などの情報をお届けいたします。

The global coagulation analyzers market is estimated to grow at a lower CAGR in developed countries; however, it is expected to witness high growth in emerging countries such as China, India, and Brazil in the next five years. Growth in the coagulation analyzers market is driven by factors such as increasing adoption of automated hemostasis instruments by diagnostics laboratories, development of high-throughput hemostasis analyzers, developments in high-sensitivity point-of-care coagulation analyzers, and introduction of technologically advanced hemostasis instruments. However, slow adoption of advanced hemostasis instruments in emerging economies and high cost of hemostasis analyzers are restraining the growth of this market.

In this report, the global coagulation analyzers market has been segmented based on the type of product (clinical laboratory analyzers, point of care testing analyzers) end users (diagnostic laboratories, stand-alone hospitals, research institutes, and other end users), Technology (mechanical, optical, electrochemical, and others), test (PT/INR, APTT, D dimer, Fibrinogen and others). The hemostasis consumables market accounted for the largest share of the global clinical laboratory analyzers market in 2014. Factors such as new product launches, development of high-throughput screening techniques, and increasing adoption of hemostasis automation platforms in laboratories are stimulating the growth of the hemostasis reagents market.

Geographically, North America commanded the largest share of the global coagulation analyzers market in 2014, followed by Europe. The coagulation analyzers market in North America is primarily driven by various factors such as technological advancements, rising incidence/prevalence of patients suffering from blood disorders, and increasing funding to research institutes. However, increasing government pressure to reduce healthcare costs, decreasing reimbursement of laboratory tests, and rising price pressure on market players are restraining the growth of the market in this region. The Asia-Pacific region is poised to grow at the highest CAGR in the next five years, owing to factors such as large patient population, increasing funding/investment towards the development of hemostasis products, and growing focus of both international and domestic players.

The global coagulation analyzers market is highly competitive, with a large number of big and small market players. As of 2014, the global coagulation analyzers market was dominated by Sysmex Corporation (Japan), Siemens Healthcare (Germany), and Roche Diagnostics (Switzerland). New product launches and expansions are the major strategies adopted by most players to achieve growth in this market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends and Porter’s five forces model), market share analysis of top players, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments in the hemostasis analyzers and reagents market, high-growth regions/countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on hemostasis analyzers and reagents offered by the top 10 players in the coagulation analyzers market. The report analyzes the coagulation analyzers market by type of product and surgery across geographies

• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the coagulation analyzers market

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various hemostasis analyzers and reagents across geographies

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the coagulation analyzers market

• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the coagulation analyzers market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 20
1.1 OBJECTIVES OF THE STUDY 20
1.2 MARKET DEFINITION 20
1.3 MARKET SCOPE 21
1.3.1 MARKETS COVERED 21
1.3.2 YEARS CONSIDERED FOR THE STUDY 22
1.4 CURRENCY 22
1.5 LIMITATIONS 22
1.6 STAKEHOLDERS 23

2 RESEARCH METHODOLOGY 24
2.1 RESEARCH DATA 24
2.2 MARKET SIZE ESTIMATION 25
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 28
2.4 MARKET SHARE ESTIMATION 29
2.5 KEY DATA FROM SECONDARY SOURCES 29
2.6 KEY DATA FROM PRIMARY SOURCES 30
2.7 KEY INDUSTRY INSIGHTS 31
2.8 ASSUMPTIONS FOR THE STUDY 31

3 EXECUTIVE SUMMARY 32

4 PREMIUM INSIGHTS 37
4.1 HIGH GROWTH POTENTIAL OF THE COAGULATION ANALYZERS MARKET 37
4.2 GLOBAL CLINICAL LABORATORY ANALYZERS, BY TYPE 38
4.3 GLOBAL COAGULATION ANALYZERS MARKET, BY REGION 39
4.4 COAGULATION ANALYZERS MARKET, BY INSTRUMENT 40
4.5 COAGULATION ANALYZERS MARKET, BY TEST 41
4.6 GLOBAL COAGULATION ANALYZERS MARKET, BY END USER 42
4.7 LIFECYCLE ANALYSIS, BY REGION 43

5 MARKET OVERVIEW 44
5.1 INTRODUCTION 45

5.2 MARKET SEGMENTATION 45
5.2.1 BY PRODUCT 45
5.2.2 BY TEST 46
5.2.3 BY TECHNOLOGY 46
5.2.4 BY END USER 47
5.2.5 BY REGION 48
5.3 MARKET DYNAMICS 49
5.4 DRIVERS 50
5.4.1 INCREASING PREVALENCE OF DISEASES AND RISING NUMBER OF SURGICAL PROCEDURES 50
5.4.2 INCREASING ADOPTION OF AUTOMATED COAGULATION INSTRUMENTS BY DIAGNOSTIC LABORATORIES 50
5.4.3 DEVELOPMENT OF HIGH-SENSITIVITY POINT-OF-CARE (POC) COAGULATION TESTING 50
5.4.4 GROWTH IN AGING POPULATION 50
5.4.5 TECHNOLOGICAL ADVANCEMENTS AND NEW PRODUCT LAUNCHES 51
5.5 RESTRAINTS 53
5.5.1 SLOW ADOPTION OF ADVANCED COAGULATION INSTRUMENTS IN EMERGING ECONOMIES 53
5.5.2 HIGH COST OF FULLY AUTOMATED COAGULATION ANALYZERS 53
5.6 OPPORTUNITIES 54
5.6.1 RAPID GROWTH IN THE COAGULATION MARKET IN EMERGING ECONOMIES 54
5.6.2 INCREASING NUMBER OF HEMOPHILIC PATIENTS 54
5.7 CHALLENGE 55
5.7.1 STRINGENT AND TIME-CONSUMING REGULATORY POLICIES 55

6 INDUSTRY INSIGHTS 56
6.1 INTRODUCTION 56
6.2 PORTER’S FIVE FORCES ANALYSIS 56
6.2.1 THREAT OF NEW ENTRANTS 57
6.2.2 THREAT OF SUBSTITUTES 57
6.2.3 BARGAINING POWER OF SUPPLIERS 57
6.2.4 BARGAINING POWER OF BUYERS 58
6.2.5 INTENSITY OF COMPETITIVE RIVALRY 58
6.3 SUPPLY CHAIN ANALYSIS 59
6.3.1 KEY INFLUENCERS 60
6.4 STRATEGIC BENCHMARKING 61

7 HEMOSTASIS/COAGULATION ANALYZERS MARKET, BY TYPE OF TEST 62
7.1 INTRODUCTION 63
7.2 PROTHROMBIN TIME (PT/INR) TEST 64
7.3 ACTIVATED CLOTTING TIME (ACT/APTT) TEST 67
7.4 D-DIMER TEST 69
7.5 FIBRINOGEN TEST 71
7.6 OTHERS COAGULATION TEST 73

8 COAGULATION ANALYZERS MARKET, BY PRODUCT TYPE 76
8.1 INTRODUCTION 77
8.2 CLINICAL LABORATORY COAGULATION ANALYZERS 78
8.2.1 INSTRUMENTS 81
8.2.1.1 Fully Automated Coagulation Analyzers 85
8.2.1.2 Semi-automated and Manual Coagulation Analyzers 87
8.2.2 COAGULATION CONSUMABLES 90
8.2.2.1 Reagents 92
8.2.2.2 Standards, Controls, and Calibrators 94
8.3 POINT-OF-CARE TESTING COAGULATION ANALYZERS 97

9 COAGULATION ANALYZERS MARKET, BY TECHNOLOGY 100
9.1 INTRODUCTION 101
9.2 PHOTO OPTICAL TECHNOLOGY 101
9.3 MECHANICAL TECHNOLOGY 102
9.4 ELECTROCHEMICAL TECHNOLOGY 102
9.5 OTHER TECHNOLOGIES 102

10 HEMOSTASIS/COAGULATION ANALYZERS MARKET, BY END USER 103
10.1 INTRODUCTION 104
10.2 RESEARCH INSTITUTES 105
10.3 DIAGNOSTIC LABORATORIES 108
10.4 STANDALONE HOSPITALS 110
10.5 OTHER END USERS 113

11 COAGULATION ANALYZERS MARKET, BY REGION 116
11.1 INTRODUCTION 117
11.2 NORTH AMERICA 121
11.2.1 U.S. 126
11.2.2 CANADA 129

11.3 EUROPE 133
11.3.1 GERMANY 136
11.3.2 FRANCE 139
11.3.3 U.K. 142
11.3.4 ITALY 145
11.3.5 SPAIN 148
11.3.6 REST OF EUROPE (ROE) 151
11.4 ASIA-PACIFIC 153
11.4.1 JAPAN 157
11.4.2 CHINA 160
11.4.3 INDIA 164
11.4.4 REST OF ASIA-PACIFIC (ROAPAC) 168
11.5 REST OF THE WORLD (ROW) 171

12 COMPETITIVE LANDSCAPE 175
12.1 OVERVIEW 175
12.2 MARKET SHARE ANALYSIS 176
12.2.1 MARKET SHARE ANALYSIS FOR CLINICAL LABORATORY ANALYZERS MARKET 176
12.2.2 MARKET SHARE ANALYSIS FOR POINT-OF-CARE COAGULATION ANALYZERS MARKET 177
12.3 COMPETITIVE SITUATION AND TRENDS 178
12.3.1 EXPANSIONS 179
12.3.2 NEW PRODUCT LAUNCHES 180
12.3.3 AGREEMENTS, PARTNERSHIPS, & ALLIANCES 181
12.3.4 ACQUISITIONS 182
12.3.5 OTHER DEVELOPMENTS 182

13 COMPANY PROFILES 183
13.1 INTRODUCTION 183
13.2 SIEMENS HEALTHCARE (A DIVISION OF SIEMENS AG) 184
13.2.1 BUSINESS OVERVIEW 184
13.2.2 SIEMENS AG: COMPANY SNAPSHOT 184
13.2.3 PRODUCT PORTFOLIO 185
13.2.4 KEY STRATEGIES 186
13.2.5 RECENT DEVELOPMENTS 186
13.3 SYSMEX CORPORATION 188
13.3.1 BUSINESS OVERVIEW 188
13.3.2 SYSMEX CORPORATION: COMPANY SNAPSHOT 188
13.3.3 PRODUCT PORTFOLIO 189
13.3.4 KEY STRATEGIES 190
13.3.5 RECENT DEVELOPMENTS 190

13.4 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.) 191
13.4.1 BUSINESS OVERVIEW 191
13.4.2 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 191
13.4.3 PRODUCT PORTFOLIO 192
13.4.4 KEY STRATEGY 192
13.4.5 RECENT DEVELOPMENTS 192
13.5 NIHON KOHDEN CORPORATION 193
13.5.1 BUSINESS OVERVIEW 193
13.5.2 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT 193
13.5.3 PRODUCT PORTFOLIO 194
13.5.4 KEY STRATEGY 194
13.5.5 RECENT DEVELOPMENTS 194
13.6 INTERNATIONAL TECHNIDYNE CORPORATION (ITC) 195
13.6.1 BUSINESS OVERVIEW 195
13.6.2 KEY FINANCIALS 195
13.6.3 PRODUCTS 195
13.6.4 KEY STRATEGY 195
13.6.5 RECENT DEVELOPMENTS 195
13.7 HELENA LABORATORIES 196
13.7.1 BUSINESS OVERVIEW 196
13.7.2 KEY FINANCIALS 196
13.7.3 PRODUCT PORTFOLIO 196
13.8 ALERE, INC. 197
13.8.1 BUSINESS OVERVIEW 197
13.8.2 ALERE, INC.: COMPANY SNAPSHOT 197
13.8.3 PRODUCT PORTFOLIO 198
13.8.4 KEY STRATEGY 198
13.9 DIAGNOSTICA STAGO SAS 199
13.9.1 BUSINESS OVERVIEW 199
13.9.2 KEY FINANCIALS 199
13.9.3 PRODUCT PORTFOLIO 199
13.9.4 KEY STRATEGY 199
13.9.5 RECENT DEVELOPMENTS 200
13.10 INSTRUMENTATION LABORATORY (A DIVISION OF THE WERFEN GROUP) 201
13.10.1 BUSINESS OVERVIEW 201
13.10.2 KEY FINANCIALS 201
13.10.3 PRODUCT PORTFOLIO 201
13.10.4 KEY STRATEGY 202
13.10.5 RECENT DEVELOPMENTS 202

13.11 THERMO FISHER SCIENTIFIC, INC. 203
13.11.1 BUSINESS OVERVIEW 203
13.11.2 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 203
13.11.3 PRODUCT PORTFOLIO 204
13.11.4 KEY STRATEGIES 204
13.11.5 RECENT DEVELOPMENTS 204

14 APPENDIX 205
14.1 INSIGHTS FROM INDUSTRY EXPERTS 205
14.2 DISCUSSION GUIDE 206
14.3 COMPANY DEVELOPMENTS (2012–2014) 209
14.3.1 SYSMEX CORPORATION 209
14.3.2 NIHON KOHEDEN CORPORATION 209
14.3.3 SIEMENS HEALTHCARE 210
14.3.4 DIAGNOSTICA STAGO, INC. 210
14.3.5 INSTRUMENTATION LABORATORY (A DIVISION OF THE WERFEN GROUP) 210
14.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 211
14.5 AVAILABLE CUSTOMIZATIONS 211
14.6 RELATED REPORTS 212

LIST OF TABLES

TABLE 1 INCREASING ADOPTION OF AUTOMATED COAGULATION INSTRUMENTS BY DIAGNOSTIC LABORATORIES TO DRIVE THE COAGULATION ANALYZERS MARKET 52
TABLE 2 HIGH COST OF FULLY AUTOMATED COAGULATION ANALYZERS RESTRAINING MARKET GROWTH 53
TABLE 3 EMERGING MARKETS OFFER SIGNIFICANT POTENTIAL FOR COAGULATION ANALYZERS 54
TABLE 4 STRINGENT REGULATORY POLICIES: A MAJOR CHALLENGE IN THE COAGULATION ANALYZERS MARKET 55
TABLE 5 COAGULATION ANALYZERS MARKET SIZE, BY TEST, 2012–2019 ($MILLION) 64
TABLE 6 PROTHROMBIN TIME (PT/INR) TESTING MARKET SIZE, BY REGION,
2012–2019 ($MILLION) 65
TABLE 7 NORTH AMERICA: PROTHROMBIN TIME (PT/INR) TESTING MARKET SIZE,
BY COUNTRY, 2012–2019 ($MILLION) 65
TABLE 8 EUROPE: PROTHROMBIN TIME (PT/INR) TESTING MARKET SIZE,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 66
TABLE 9 APAC: PROTHROMBIN TIME (PT/INR) TESTING MARKET SIZE,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 66
TABLE 10 ACTIVATED CLOTTING TIME (ACT/APTT) TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 67
TABLE 11 NORTH AMERICA: ACTIVATED CLOTTING TIME (ACT/APTT) TESTING MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 68
TABLE 12 EUROPE: ACTIVATED CLOTTING TIME (ACT/APTT) TESTING MARKET SIZE,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 68
TABLE 13 APAC: ACTIVATED CLOTTING TIME (ACT/APTT) TESTING MARKET SIZE,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 69
TABLE 14 D-DIMER TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 69
TABLE 15 NORTH AMERICA: D-DIMER TESTING MARKET SIZE, BY COUNTRY,
2012–2019 ($MILLION) 70
TABLE 16 EUROPE: D-DIMER TESTING MARKET SIZE, BY COUNTRY/REGION,
2012–2019 ($MILLION) 70
TABLE 17 APAC: D-DIMER TESTING MARKET SIZE, BY COUNTRY/REGION,
2012–2019 ($MILLION) 71
TABLE 18 FIBRINOGEN TESTING MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 71
TABLE 19 NORTH AMERICA: FIBRINOGEN TESTING MARKET SIZE, BY COUNTRY,
2012–2019 ($MILLION) 72
TABLE 20 EUROPE: FIBRINOGEN TESTING MARKET SIZE, BY COUNTRY/REGION,
2012–2019 ($MILLION) 72
TABLE 21 APAC: FIBRINOGEN TESTING MARKET SIZE, BY COUNTRY/REGION,
2012–2019 ($MILLION) 73
TABLE 22 OTHER TESTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 74
TABLE 23 NORTH AMERICA: OTHER TESTS MARKET SIZE, BY COUNTRY,
2012–2019 ($MILLION) 74
TABLE 24 EUROPE: OTHER TESTS MARKET SIZE, BY COUNTRY/REGION,
2012–2019 ($MILLION) 75
TABLE 25 APAC: OTHER TESTS MARKET SIZE, BY COUNTRY/REGION,
2012–2019 ($MILLION) 75
TABLE 26 COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 77
TABLE 27 CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 79
TABLE 28 CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY REGION, 2012–2019 ($MILLION) 79
TABLE 29 NORTH AMERICA: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 80
TABLE 30 EUROPE: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 80
TABLE 31 APAC: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 81
TABLE 32 COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 82
TABLE 33 COAGULATION INSTRUMENTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 83
TABLE 34 NORTH AMERICA: COAGULATION INSTRUMENTS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 83
TABLE 35 EUROPE: COAGULATION INSTRUMENTS MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($MILLION) 84
TABLE 36 APAC: COAGULATION INSTRUMENTS MARKET SIZE, BY COUNTRY/REGION,
2012–2019 ($MILLION) 84
TABLE 37 FULLY AUTOMATED COAGULATION ANALYZERS MARKET SIZE, BY REGION,
2012–2019 ($MILLION) 85
TABLE 38 NORTH AMERICA: FULLY AUTOMATED COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 86
TABLE 39 EUROPE: FULLY AUTOMATED COAGULATION ANALYZERS MARKET SIZE,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 86
TABLE 40 APAC: FULLY AUTOMATED COAGULATION ANALYZERS MARKET SIZE,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 87
TABLE 41 SEMI-AUTOMATED AND MANUAL COAGULATION ANALYZERS MARKET SIZE,
BY REGION, 2012–2019 ($MILLION) 88
TABLE 42 NORTH AMERICA: SEMI-AUTOMATED AND MANUAL COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 88
TABLE 43 EUROPE: SEMI-AUTOMATED AND MANUAL COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($MILLION) 89
TABLE 44 APAC: SEMI-AUTOMATED AND MANUAL COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($MILLION) 89
TABLE 45 COAGULATION CONSUMABLES MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 90
TABLE 46 COAGULATION CONSUMABLES MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 90
TABLE 47 NORTH AMERICA: COAGULATION CONSUMABLES MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 91
TABLE 48 EUROPE: COAGULATION CONSUMABLES MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($MILLION) 91
TABLE 49 APAC: COAGULATION CONSUMABLES MARKET SIZE, BY COUNTRY/REGION,
2012–2019 ($MILLION) 92
TABLE 50 COAGULATION REAGENTS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 92
TABLE 51 NORTH AMERICA: COAGULATION REAGENTS MARKET SIZE, BY COUNTRY,
2012–2019 ($MILLION) 93
TABLE 52 EUROPE: COAGULATION REAGENTS MARKET SIZE, BY COUNTRY/REGION,
2012–2019 ($MILLION) 93
TABLE 53 APAC: COAGULATION REAGENTS MARKET SIZE, BY COUNTRY/REGION,
2012–2019 ($MILLION) 94
TABLE 54 COAGULATION STANDARDS, CALIBRATORS, AND CONTROLS MARKET SIZE,
BY REGION, 2012–2019 ($MILLION) 95
TABLE 55 NORTH AMERICA: COAGULATION STANDARDS, CALIBRATORS, AND CONTROLS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 95
TABLE 56 EUROPE: COAGULATION STANDARDS, CALIBRATORS, AND CONTROLS MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($MILLION) 96
TABLE 57 APAC: COAGULATION STANDARDS, CALIBRATORS, AND CONTROLS MARKET SIZE, BY COUNTRY/REGION, 2012–2019 ($MILLION) 96
TABLE 58 POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 98
TABLE 59 NORTH AMERICA: POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION) 98
TABLE 60 EUROPE: POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET SIZE,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 99
TABLE 61 APAC: POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET SIZE,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 99
TABLE 62 COAGULATION ANALYZERS MARKET SIZE, BY END USER, 2012–2019 ($MILLION) 105
TABLE 63 COAGULATION ANALYZERS MARKET SIZE FOR RESEARCH INSTITUTES,
BY REGION, 2012–2019 ($MILLION) 106
TABLE 64 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY, 2012–2019 ($MILLION) 106
TABLE 65 EUROPE: COAGULATION ANALYZERS MARKET SIZE FOR RESEARCH INSTITUTES, BY COUNTRY/REGION, 2012–2019 ($MILLION) 107
TABLE 66 APAC: COAGULATION ANALYZERS MARKET SIZE FOR RESEARCH INSTITUTES,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 107
TABLE 67 COAGULATION ANALYZERS MARKET SIZE FOR DIAGNOSTIC LABORATORIES,
BY REGION, 2012–2019 ($MILLION) 108
TABLE 68 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2012–2019 ($MILLION) 109
TABLE 69 EUROPE: COAGULATION ANALYZERS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2012–2019 ($MILLION) 109
TABLE 70 APAC: COAGULATION ANALYZERS MARKET SIZE FOR DIAGNOSTIC LABORATORIES, BY COUNTRY/REGION, 2012–2019 ($MILLION) 110
TABLE 71 COAGULATION ANALYZERS MARKET SIZE FOR STANDALONE HOSPITALS,
BY REGION, 2012–2019 ($MILLION) 111
TABLE 72 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE FOR STANDALONE HOSPITALS, BY COUNTRY, 2012–2019 ($MILLION) 111
TABLE 73 EUROPE: COAGULATION ANALYZERS MARKET SIZE FOR STANDALONE HOSPITALS, BY COUNTRY/REGION, 2012–2019 ($MILLION) 112
TABLE 74 APAC: COAGULATION ANALYZERS MARKET SIZE FOR STANDALONE HOSPITALS,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 112
TABLE 75 COAGULATION ANALYZERS MARKET SIZE FOR OTHERS, BY REGION,
2012–2019 ($MILLION) 114
TABLE 76 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE FOR OTHERS,
BY COUNTRY, 2012–2019 ($MILLION) 114
TABLE 77 EUROPE: COAGULATION ANALYZERS MARKET SIZE FOR OTHERS,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 115
TABLE 78 APAC: COAGULATION ANALYZERS MARKET SIZE FOR OTHERS,
BY COUNTRY/REGION, 2012–2019 ($MILLION) 115
TABLE 79 COAGULATION ANALYZERS MARKET SIZE, BY REGION, 2012–2019 ($MILLION) 118
TABLE 80 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY,
2012–2019 ($MILLION) 118
TABLE 81 EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY/REGION,
2012–2019 ($MILLION) 119
TABLE 82 APAC: COAGULATION ANALYZERS MARKET SIZE, BY COUNTRY/REGION,
2012–2019 ($MILLION) 120
TABLE 83 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2012-2019 ($MILLION) 123
TABLE 84 NORTH AMERICA: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 123
TABLE 85 NORTH AMERICA: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 124
TABLE 86 NORTH AMERICA: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 124
TABLE 87 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST, 2012-2019 ($MILLION) 125
TABLE 88 NORTH AMERICA: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012-2019 ($MILLION) 125
TABLE 89 U.S.: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 127
TABLE 90 U.S.: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 127
TABLE 91 U.S.: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 127
TABLE 92 U.S.: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 128
TABLE 93 U.S.: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 128
TABLE 94 U.S.: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 129
TABLE 95 CANADA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 130
TABLE 96 CANADA: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 130
TABLE 97 CANADA: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 131
TABLE 98 CANADA: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 131
TABLE 99 CANADA: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 132
TABLE 100 CANADA: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 132
TABLE 101 EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 134
TABLE 102 EUROPE: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 134
TABLE 103 EUROPE: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 134
TABLE 104 EUROPE: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 135
TABLE 105 EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 135
TABLE 106 EUROPE: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 136
TABLE 107 GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 137
TABLE 108 GERMANY: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 137
TABLE 109 GERMANY: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 137
TABLE 110 GERMANY: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 138
TABLE 111 GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 138
TABLE 112 GERMANY: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 139
TABLE 113 FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 140
TABLE 114 FRANCE: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 140
TABLE 115 FRANCE: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 140
TABLE 116 FRANCE: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 141
TABLE 117 FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 141
TABLE 118 FRANCE: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 142
TABLE 119 U.K.: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 142
TABLE 120 U.K.: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 143
TABLE 121 U.K.: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 143
TABLE 122 U.K.: CONSUMABLES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION) 144
TABLE 123 U.K.: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 144
TABLE 124 U.K.: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 145
TABLE 125 ITALY: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 145
TABLE 126 ITALY: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 146
TABLE 127 ITALY: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 146
TABLE 128 ITALY: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 146
TABLE 129 ITALY: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 147
TABLE 130 ITALY: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 147
TABLE 131 SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 148
TABLE 132 SPAIN: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 149
TABLE 133 SPAIN: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 149
TABLE 134 SPAIN: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 149
TABLE 135 SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 150
TABLE 136 SPAIN: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 150
TABLE 137 ROE: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 151
TABLE 138 ROE: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 151
TABLE 139 ROE: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 152
TABLE 140 ROE: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 152
TABLE 141 ROE: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 153
TABLE 142 ROE: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 153
TABLE 143 ASIA-PACIFIC: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 155
TABLE 144 ASIA-PACIFIC: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 155
TABLE 145 ASIA-PACIFIC: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 155
TABLE 146 ASIA-PACIFIC: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 156
TABLE 147 ASIA-PACIFIC: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 156
TABLE 148 ASIA-PACIFIC: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 157
TABLE 149 JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 157
TABLE 150 JAPAN: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 158
TABLE 151 JAPAN: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 158
TABLE 152 JAPAN: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 159
TABLE 153 JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 159
TABLE 154 JAPAN: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 160
TABLE 155 CHINA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 161
TABLE 156 CHINA: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 161
TABLE 157 CHINA: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 162
TABLE 158 CHINA: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 162
TABLE 159 CHINA: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 163
TABLE 160 CHINA: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 163
TABLE 161 INDIA: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 165
TABLE 162 INDIA: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 166
TABLE 163 INDIA: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 166
TABLE 164 INDIA: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 166
TABLE 165 INDIA: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 167
TABLE 166 INDIA: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 167
TABLE 167 ROAPAC: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 168
TABLE 168 ROAPAC: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 168
TABLE 169 ROAPAC: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 169
TABLE 170 ROAPAC: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 169
TABLE 171 ROAPAC: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 170
TABLE 172 ROA: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 170
TABLE 173 ROW: COAGULATION ANALYZERS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 172
TABLE 174 ROW: CLINICAL LABORATORY COAGULATION ANALYZERS MARKET SIZE,
BY PRODUCT TYPE, 2012–2019 ($MILLION) 172
TABLE 175 ROW: COAGULATION INSTRUMENTS MARKET SIZE, BY PRODUCT TYPE,
2012–2019 ($MILLION) 173
TABLE 176 ROW: CONSUMABLES MARKET SIZE, BY PRODUCT TYPE, 2012–2019 ($MILLION) 173
TABLE 177 ROW: COAGULATION ANALYZERS MARKET SIZE, BY TYPE OF TEST,
2012–2019 ($MILLION) 174
TABLE 178 ROW: COAGULATION ANALYZERS MARKET SIZE, BY END USER,
2012–2019 ($MILLION) 174
TABLE 179 RECENT EXPANSION, 2012–2015 179
TABLE 180 RECENT NEW PRODUCT LAUNCHES, 2012–2015 180
TABLE 181 RECENT AGREEMENTS, PARTNERSHIPS, & COLLABORATIONS, 2012–2015 181
TABLE 182 RECENT ACQUISITIONS, 2012-2015 182
TABLE 183 RECENT OTHER DEVELOPMENTS, 2014 182


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 24
FIGURE 2 TOP-DOWN APPROACH 26
FIGURE 3 BOTTOM-UP APPROACH 26
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 27
FIGURE 5 DATA TRIANGULATION METHODOLOGY 28
FIGURE 6 NORTH AMERICA TO DOMINATE THE COAGULATION ANALYZERS MARKET 32
FIGURE 7 PT/INR SEGMENT WILL CONTINUE TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD 33
FIGURE 8 STANDALONE HOSPITALS SEGMENT WILL BE THE LARGEST END-USER SEGMENT IN THE COAGULATION ANALYZERS MARKET 34
FIGURE 9 COAGULATION ANALYZERS MARKET, BY REGION, 2014 35
FIGURE 10 POINT-OF-CARE TESTING ANALYZERS SEGMENT TO GROW AT THE HIGHEST CAGR 37
FIGURE 11 CONSUMABLES SEGMENT HELD THE LARGEST MARKET SHARE IN 2014 38
FIGURE 12 U.S. COMMANDS THE LARGEST SHARE OF THE MARKET 39
FIGURE 13 FULLY AUTOMATED ANALYZERS SEGMENT DOMINATES MARKET 40
FIGURE 14 8.5% OF THE GROWTH IS EXPECTED TO COME FROM PT/INR SEGMENT DURING FORECAST PERIOD 41
FIGURE 15 STANDALONE HOSPITALS WILL CONTINUE TO LEAD THE COAGULATION ANALYZERS END-USERS MARKET DURING THE FORECAST PERIOD 42
FIGURE 16 ASIA-PACIFIC TO WITNESS HIGH GROWTH DURING FORECAST PERIOD 43
FIGURE 17 COAGULATION ANALYZERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
FIGURE 18 PORTER’S FIVE FORCES ANALYSIS 56
FIGURE 19 SUPPLY CHAIN ANALYSIS 59
FIGURE 20 STRATEGIC BENCHMARKING: SYSMEX CORPORATION LARGELY ADOPTED ORGANIC GROWTH STRATEGIES TO ENHANCE ITS PRODUCT OFFERINGS 61
FIGURE 21 PT/INR SEGMENT WILL CONTINUE TO DOMINATE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD 63
FIGURE 22 CONSUMABLES SEGMENT WILL DRIVE THE COAGULATION ANALYZERS MARKET DURING THE FORECAST PERIOD 78
FIGURE 23 FULLY AUTOMATED ANALYZERS SEGMENT IS THE FASTEST-GROWING SEGMENT DURING THE FORECAST PERIOD 82
FIGURE 24 ASIA-PACIFIC IS THE FASTEST-GROWING REGION IN POINT-OF-CARE TESTING COAGULATION ANALYZERS MARKET DURING FORECAST PERIOD 97
FIGURE 25 PHOTO OPTICAL TECHNOLOGY ACCOUNTED FOR THE LARGEST SHARE OF THE COAGULATION ANALYZERS MARKET, BY TECHNOLOGY 101
FIGURE 26 THE STANDALONE HOSPITALS SEGMENT IS EXPECTED TO DRIVE THE GROWTH OF THE COAGULATION ANALYZERS MARKET IN THE FORECAST PERIOD 104
FIGURE 27 GEOGRAPHIC SNAPSHOT (2014): EMERGING MARKETS HOLD SIGNIFICANT GROWTH OPPORTUNITIES FOR COAGULATION ANALYZERS 117
FIGURE 28 THE CONSUMABLES SEGMENT WILL CONTINUE TO DRIVE THE COAGULATION ANALYZERS MARKET IN THE FORECAST PERIOD 118
FIGURE 29 INCREASING INVESTMENTS FOR THE DEVELOPMENT OF COAGULATION ANALYZERS ARE DRIVING MARKET GROWTH 122
FIGURE 30 GERMANY WILL CONTINUE TO DOMINATE THE EUROPEAN COAGULATION ANALYZERS MARKET IN THE FORECAST PERIOD 133
FIGURE 31 COAGULATION ANALYZERS MARKET IN ASIA-PACIFIC TO GROW AT THE HIGHEST CAGR IN THE FORECAST PERIOD 154
FIGURE 32 CLINICAL LABORATORY ANALYZERS MARKET IN INDIA HAS HIGH GROWTH POTENTIAL IN 2019 165
FIGURE 33 THE CONSUMABLES SEGMENT WILL DOMINATE THE ROW CLINICAL LABORATORY ANALYZERS MARKET IN 2019 171
FIGURE 34 NEW PRODUCT LAUNCHES WAS THE PREFERRED STRATEGY FOR MAJOR PLAYERS IN THE COAGULATION ANALYZERS MARKET 175
FIGURE 35 GLOBAL CLINICAL LABORATORY ANALYZERS MARKET SHARE,
BY KEY PLAYER, 2014 176
FIGURE 36 GLOBAL POINT-OF-CARE COAGULATION ANALYZERS MARKET SHARE,
BY KEY PLAYER, 2014 177
FIGURE 37 BATTLE FOR MARKET SHARE: EXPANSION WAS THE KEY STRATEGY ADOPTED
BY MARKET PLAYERS 178
FIGURE 38 GEOGRAPHIC REVENUE MIX FOR TOP 3 MARKET PLAYERS 183


【レポートのキーワード】

血液凝固分析装置、血液凝固分析技術、血液凝固分析試薬、消耗品、血液凝固検査

★調査レポート[血液凝固分析装置の世界市場] ( Coagulation/Hemostasis Analyzer Market by Product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institutes, Hospitals) - Forecast to 2019 / MAM-MD-3255) 販売に関する免責事項
[血液凝固分析装置の世界市場] ( Coagulation/Hemostasis Analyzer Market by Product (Automated, POC), Consumables (Reagents, Standards), Test Type (APTT, Prothrombin Time/INR, D-Dimer, Fibrinogen), Technology (Mechanical, Optical), End Users (Research Institutes, Hospitals) - Forecast to 2019 / MAM-MD-3255) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆